In MM, STAT3 was shown to recruit CBP/p300 coactivators for the transactivation of its target genes, a process in which SRC-1 is generally not required, and thereby promotes growth and inhibits apoptosis of MM cells [38, 39]. Here, SRC is linked to Miyoshi myopathy.